Alzheimer's Matters Blog

Combination Therapy

Developing Drugs

Combination Therapy: The Right Approach for Alzheimer’s

Learn why combination therapy holds such promise for treating Alzheimer's disease, and why Amylyx's drug is the first such therapy we are funding.

Howard Fillit and D. Martin Watterson

ADDF Impact

Driving Innovation in Alzheimer’s Therapies

At our 18th Annual Conference on Alzheimer’s Drug Discovery in Jersey City, the impact of our approach will take center stage.

Marathon Team Member Jeanette Arahood

Supporter Stories

Stealing Memories

Jeanette Arahood explains how her patients inspired her to join our TCS New York City Marathon team.

Brain inflammation

ADDF Impact

Inflammation, The Driver of Alzheimer’s Disease?

A growing body of evidence suggests that inflammation in the brain is implicated in the development of Alzheimer's.

Football players and CTE

Understanding Dementia

Contact Sports & CTE: Are the Risks Too High?

A new study reveals a high percentage of former football players died with CTE, including 99% of NFL players tested.

MacKay Jimeson, Daniel Skovronsky, Lauren Friedman

Developing Drugs

Three Themes Emerge at BIO2017

Dr. Lauren Friedman details the three topics that dominated discussions at this year's BIO International Convention.